QPCTL is a Small Molecule Drug Target Modulating the Innate Immune Response

Time: 2:00 pm
day: Day Two Track A PM

Details:

  • Identification of QPCTL as a new target that impacts CD47 and several chemokines
  • Preclinical evaluation of QPCTL inhibition

Speakers: